BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24607909)

  • 21. VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment.
    Murakami M; Zheng Y; Hirashima M; Suda T; Morita Y; Ooehara J; Ema H; Fong GH; Shibuya M
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):658-64. PubMed ID: 18174461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW 264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor.
    Islam S; Hassan F; Tumurkhuu G; Dagvadorj J; Koide N; Naiki Y; Yoshida T; Yokochi T
    Microbiol Immunol; 2008 Dec; 52(12):585-90. PubMed ID: 19120972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
    Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
    J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Origin of giant cells in osteoclast-like giant cell tumors of the pancreas.
    Sakai Y; Kupelioglu AA; Yanagisawa A; Yamaguchi K; Hidaka E; Matsuya S; Ohbuchi T; Tada Y; Saisho H; Kato Y
    Hum Pathol; 2000 Oct; 31(10):1223-9. PubMed ID: 11070115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
    Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
    J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor and Antimetastatic Activity of Synthetic Hydroxystilbenes Through Inhibition of Lymphangiogenesis and M2 Macrophage Differentiation of Tumor-associated Macrophages.
    Kimura Y; Sumiyoshi M; Baba K
    Anticancer Res; 2016 Jan; 36(1):137-48. PubMed ID: 26722037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphangiogenesis in chronic inflammation in the testis.
    Hirai S; Naito M; Terayama H; Qu N; Kuerban M; Musha M; Itoh M
    Andrology; 2013 Jan; 1(1):147-54. PubMed ID: 23258644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst.
    Taylor RM; Kashima TG; Hemingway FK; Dongre A; Knowles HJ; Athanasou NA
    Lab Invest; 2012 Apr; 92(4):600-5. PubMed ID: 22330339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast carcinoma with osteoclast-like giant cells: A cytological-pathological correlation with a literature review.
    Ohashi R; Hayama A; Matsubara M; Watarai Y; Sakatani T; Naito Z; Shimizu A
    Ann Diagn Pathol; 2018 Apr; 33():1-5. PubMed ID: 29566940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD137L- and RANKL-mediated reverse signals inhibit osteoclastogenesis and T lymphocyte proliferation.
    Senthilkumar R; Lee HW
    Immunobiology; 2009; 214(2):153-61. PubMed ID: 19167994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
    Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
    Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
    Takeshita S; Kaji K; Kudo A
    J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression.
    Hie M; Tsukamoto I
    J Nutr Biochem; 2011 Feb; 22(2):164-71. PubMed ID: 20444587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of vascular endothelial growth factor on RANK gene expression in osteoclast precursors and on osteoclastogenesis.
    Yao S; Liu D; Pan F; Wise GE
    Arch Oral Biol; 2006 Jul; 51(7):596-602. PubMed ID: 16443190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage lineage phenotypes and osteoclastogenesis--complexity in the control by GM-CSF and TGF-beta.
    Lari R; Fleetwood AJ; Kitchener PD; Cook AD; Pavasovic D; Hertzog PJ; Hamilton JA
    Bone; 2007 Feb; 40(2):323-36. PubMed ID: 17055352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related production of osteoclasts and the changes of serum levels of vascular endothelial growth factor (VEGF) and receptor activator for nuclear factor (NF)-κB ligand (RANKL) in osteopetrotic (op/op) mice.
    Motokawa M; Tsuka N; Kaku M; Kawata T; Fujita T; Ohtani J; Matsuda Y; Terao A; Tanne K
    Arch Oral Biol; 2012 Apr; 57(4):352-6. PubMed ID: 21982254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
    Chikatsu N; Takeuchi Y; Tamura Y; Fukumoto S; Yano K; Tsuda E; Ogata E; Fujita T
    Biochem Biophys Res Commun; 2000 Jan; 267(2):632-7. PubMed ID: 10631114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.